Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Extended Peginterferon Alpha 2a(PEG-IFN a-2a) Treatment in HBeAg Positive Chronic Hepatitis B Patients

NCT02387463 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.

NCT NCT02387463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02387463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Extended Peginterferon Alpha 2a(PEG-IFN a-2a) Treatment in HBeAg Positive Chronic Hepatitis B Patients
Lead sponsor
Beijing Ditan Hospital
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
May 21, 2017
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b